Cargando…

Soluble ST2 protein in chronic heart failure is independent of traditional factors

INTRODUCTION: ST2 protein is the interleukin 33 (IL-33) receptor, whose serum level depends on the biomechanical strain of cardiac myocytes. The aim of this study was to analyse the relationship between soluble ST2 (sST2) level and traditional factors in patients with chronic heart failure. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wojtczak-Soska, Karolina, Pietrucha, Tadeusz, Sakowicz, Agata, Lelonek, Malgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2013
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598130/ https://www.ncbi.nlm.nih.gov/pubmed/23515651 http://dx.doi.org/10.5114/aoms.2013.33344

Ejemplares similares

Genetic Polymorphisms and the Risk of Myocardial Infarction in Patients Under 45 Years of Age
por: Sakowicz, Agata, et al.
Publicado: (2012)

Genetic variability and the risk of myocardial infarction in Poles under 45 years of age
por: Sakowicz, Agata, et al.
Publicado: (2010)

Diagnostic utility of biomarkers of left ventricular stress in patients with aortic stenosis and preserved left ventricular ejection fraction
por: Sobczak, Sebastian, et al.
Publicado: (2017)

The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2017)

Reduction in CgA-Derived CST Protein Level in HTR-8/SVneo and BeWo Trophoblastic Cell Lines Caused by the Preeclamptic Environment
por: Bralewska, Michalina, et al.
Publicado: (2023)

Preeclampsia and Related Cardiovascular Risk: Common Genetic Background
por: Lisowska, Michalina, et al.
Publicado: (2018)

Chromogranin A: An Endocrine Factor of Pregnancy
por: Bralewska, Michalina, et al.
Publicado: (2023)

Arg389Gly β1-adrenergic receptor polymorphism and susceptibility to syncope during tilt test
por: Żelazowska, Monika, et al.
Publicado: (2014)

Reliability of Rodent and Rabbit Models in Preeclampsia Research
por: Sakowicz, Agata, et al.
Publicado: (2022)

Soluble ST2 in the prediction of heart failure and death in patients with atrial fibrillation
por: Krittayaphong, Rungroj, et al.
Publicado: (2022)

New Ideas for the Prevention and Treatment of Preeclampsia and Their Molecular Inspirations
por: Sakowicz, Agata, et al.
Publicado: (2023)

The need to apply the best therapy in heart failure – the era after PARADIGM-HF
por: Lelonek, Malgorzata
Publicado: (2016)

Angiotensin receptor/neprilysin inhibitor—a breakthrough in chronic heart failure therapy: summary of subanalysis on PARADIGM-HF trial findings
por: Książczyk, Marcin, et al.
Publicado: (2019)

The impact of chronic kidney disease on the annual prognosis in patients 80+ years old suffering from chronic heart failure
por: Cichocka-Radwan, Anna, et al.
Publicado: (2014)

Association of Maternal and Fetal Single-Nucleotide Polymorphisms in Metalloproteinase (MMP1, MMP2, MMP3, and MMP9) Genes with Preeclampsia
por: Sakowicz, Agata, et al.
Publicado: (2018)

Double hit of NEMO gene in preeclampsia
por: Sakowicz, Agata, et al.
Publicado: (2017)

Biomarkers Beyond the Natriuretic Peptides for Chronic Heart Failure: Galectin-3 and Soluble ST2
por: Wu, Alan H.B.
Publicado: (2012)

Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients
por: Crnko, Sandra, et al.
Publicado: (2020)

The Diagnostic Accuracy of N-Terminal Pro-B-Type Natriuretic Peptide and Soluble ST2 for Heart Failure in Chronic Kidney Disease Patients: A Comparative Analysis
por: Ma, Hongzhen, et al.
Publicado: (2023)

Placental Expression of NEMO Protein in Normal Pregnancy and Preeclampsia
por: Sakowicz, Agata, et al.
Publicado: (2019)

The soluble ST2 levels in patients with depression and comorbid heart failure
por: Sikora, A., et al.
Publicado: (2022)

Differential and Predictive Value of Galectin-3 and Soluble Suppression of Tumorigenicity-2 (sST2) in Heart Failure with Preserved Ejection Fraction
por: Cui, Yameng, et al.
Publicado: (2018)

Identification of placental genes linked to selective intrauterine growth restriction (IUGR) in dichorionic twin pregnancies: gene expression profiling study
por: Biesiada, Lidia, et al.
Publicado: (2019)

Chromogranin A demonstrates higher expression in preeclamptic placentas than in normal pregnancy
por: Bralewska, Michalina, et al.
Publicado: (2021)

Prognostic Significance of Serum Interleukins and Soluble ST2 in Traditional Chinese Medicine (TCM) Syndrome-Differentiated Rheumatoid Arthritis
por: Wang, Yu, et al.
Publicado: (2018)

Where are we in 2021 with heart failure with reduced ejection fraction?—current outlook and expectations from new promising clinical trials
por: Dębska-Kozłowska, Agnieszka, et al.
Publicado: (2021)

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure
por: Villacorta, Humberto, et al.
Publicado: (2016)

Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
por: Yalta, Kenan, et al.
Publicado: (2018)

The Diagnostic Value of Soluble ST2 in Heart Failure: A Meta-Analysis
por: Yang, Chaojun, et al.
Publicado: (2021)

Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction
por: Tymińska, Agata, et al.
Publicado: (2019)

Factors Associated with Heart Failure Knowledge and Adherence to Self-Care Behaviors in Hospitalized Patients with Acute Decompensated Heart Failure Based on Data from “the Weak Heart” Educational Program
por: Kolasa, Jolanta, et al.
Publicado: (2021)

The GLVC scoring system: a single-center model for predicting survival and hospitalization in patients with heart failure
por: Chuda-Wietczak, Anna, et al.
Publicado: (2023)

The Prognostic Value of Plasma Soluble ST2 in Hospitalized Chinese Patients with Heart Failure
por: Zhang, Rongcheng, et al.
Publicado: (2014)

Hemodynamic Differences between Patients Hospitalized with Acutely Decompensated Chronic Heart Failure and De Novo Heart Failure
por: Galas, Agata, et al.
Publicado: (2023)

The Preeclamptic Environment Promotes the Activation of Transcription Factor Kappa B by P53/RSK1 Complex in a HTR8/SVneo Trophoblastic Cell Line
por: Sakowicz, Agata, et al.
Publicado: (2021)

Soluble ST2 and Galectin-3 and Progression of CKD
por: Alam, Mariam L., et al.
Publicado: (2018)

Elevated Plasma Soluble ST2 Is Associated with Heart Failure Symptoms and Outcome in Aortic Stenosis
por: Lancellotti, Patrizio, et al.
Publicado: (2015)

Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community‐Dwelling Population
por: Parikh, Ravi H., et al.
Publicado: (2016)

Soluble ST2 correlates with some indicators of right ventricular function in hypertensive heart failure
por: Ojji, Dike B, et al.
Publicado: (2017)

Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure
por: Wang, Zeyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oar4vttvc52hh0d8h43s8c0q6o